MedPath

Effects of Physical Exercise on Response to Treatement in Breast Cancer

Not Applicable
Active, not recruiting
Conditions
Breast Cancer
Interventions
Behavioral: High-intensiy interval training
Registration Number
NCT06522971
Lead Sponsor
Latvian Biomedical Research and Study Centre
Brief Summary

The goal of this clinical trial is to learn how regular physical exercise affects breast cancer patients' response to standard neoadjuvant chemotherapy (NAC) and to gain an insight into the molecular mechanisms underlying the effects of exercise on cancer biology. of exercise-induced alterations in cancer gene expression and the immune tumor microenvironment. The main questions it aims to answer are:

* Does a high-intensity interval training (HIIT) program during treatment improve patients' response to NAC and quality of life as compared to low level of physical activity during the treatment?

* What are the differences in the residual tumor gene expression and tumor infiltrating immune cell profile between patients taking HIIT during the NAC and patients with low level of physical activity?

* What are the roles of extracellular vesicles (EVs) in mediating the effects of exercise on cancer progression?

Patients in HIIT group will undergo a personalized HIIT program consisting of 3 training sessions per week for the whole duration of NAC, whereas patients from the control group (Ctrl) will be advised to maintain their usual level of physical activity during NAC. After the breast surgery, response to NAC will be assessed by Miller-Payne grading. Tumor and normal breast tissue specimens will be collected for RNA sequencing analysis. Blood samples will be collected before and immediately after the training for the analysis of RNA and protein cargo of circulating EVs.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
Female
Target Recruitment
55
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
High-intensity interval training (HIIT)High-intensiy interval trainingHigh-intensity interval training during neoadjuvant chemotherapy
Primary Outcome Measures
NameTimeMethod
Miller-Payne grade6 months

Response to NAC assessed by histological examination of residual tumor at surgery using Miller-Payne grading from 1 to 5, where grade 1 means no response or some alterations to individual malignant cells but no reduction in overall cellularity, whereas grade 5 is a pathological complete response.

Gene expression profile12 months

Alterations in the tumor gene expression profile will be assessed by RNA sequencing of surgical tumor and normal breast tissue specimens

Secondary Outcome Measures
NameTimeMethod
Protein cargo of extracellular vesiclesBefore intervention and after 6 months

Exercise-induced alterations in the protein cargo of circulating extracellular vesicles will be studied by proteomic analysis

Breast cancer-related quality of life6 months

Breast cancer-related quality of life assessed by the European Organisation for Research and Treatment of Cancer Breast cancer module (EORTC QLQ-B23) questionnaire that includes 23 questions addressing disease symptoms, treatment side effects, body image, sexual functioning, and future perspectives. All scales and single-item measures yield scores ranging from 0 to 100.

30 sec sit-to-stand testBefore intervention and after 6 months

The number of sit- and stand-up movement repetitions achieved during 30 sec will be recorded

6-minute walk testBefore intervention and after 6 months

The test will be performed indoors on 30 m long testing course and length of walked distance will be measured

Number and phenotype of tumor-infiltrating immune cells12 months

Immunophenotyping of tumor-infiltrating immune cells will be performed by multiplex immunofluorescence in breast tumor tissue specimens

Global health-related quality of life6 months

Global health-related quality of life will be assessed by the European Organisation for Research and Treatment of Cancer quality of life questionnaire (EORTC QLQ-C30). All scales and single-item measures yield scores ranging from 0 to 100. A high score on a functional scale indicates superior functioning and a high score on the global health status/QoL scale indicates a high quality of life. Conversely, a high score on a symptom scale or item indicates a heightened level of health complaints and/ or presence of treatment side effects.

VO2 peakBefore intervention and after 6 months

Oxygen peak consumption will be measured by UNCCRI treadmill protocol

RNA cargo of extracellular vesiclesBefore intervention and after 6 months

Exercise-induced alterations in the RNA cargo of circulating extracellular vesicles will be studied by RNA sequencing

Trial Locations

Locations (1)

Latvian Biomedical Research and Study centre

🇱🇻

Riga, Select One, Latvia

© Copyright 2025. All Rights Reserved by MedPath